Key result
Management proposals for Glanzmann's Thrombasthenia rely on expert opinion and limited evidence, utilizing local measures, antifibrinolytics, platelet transfusions, and recombinant Factor VII.
Population
Patients with Glanzmann's Thrombasthenia (GT), a rare autosomal recessive bleeding disorder
Design
Review
Authors
Loading...
Expert proposals for Glanzmann's Thrombasthenia warrant cautious adoption; leaves open the need for prospective trials to guide care.
Provides proposals for the clinical management of Glanzmann's Thrombasthenia based on expert opinion and limited evidence, highlighting the need for prospective data collection.
Minno et al. (2009) conducted a review in Glanzmann's Thrombasthenia. Clinical management strategies was evaluated. Management proposals for Glanzmann's Thrombasthenia rely on expert opinion and limited evidence, utilizing local measures, antifibrinolytics, platelet transfusions, and recombinant Factor VII.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: